- Details
- Hits: 1375
New Springer book deals with the use of cannabis in medicine and provides an evidence-based approach as well as different perspectives on this controversial issue.
- Details
- Hits: 1343
This study found:
- Children’s risk of marijuana and alcohol use and attitudes toward marijuana were influenced by their parents’ marijuana use pattern over time.
- Children whose parents used marijuana primarily during adolescence/early adulthood and those whose parents continued to use marijuana from adolescence through adulthood were at highest risk.
When parents use drugs such as marijuana, their children may also be affected. Numerous studies have shown that current parental marijuana use increases the children’s risk of substance use and other psychiatric problems. A recent NIDA-sponsored study demonstrates that the parents’ history of marijuana use throughout their lifetime may also affect their children’s outcomes and that some lifetime use patterns are more harmful than others
- Details
- Hits: 1561
Check Also,
Marijuana Potency and this link too Phytochemistry of Cannabis sativa L
- Details
- Hits: 1501
Published July 6, 2020 Research Article https://doi.org/10.1177/1073110520935338
Abstract: Cannabis use in some individuals can meaningfully introduce de novo risk for the initiation of opioid use and development of opioid use disorder. These risks may be particularly high during adolescence when cannabis use may disrupt critical periods of neurodevelopment. Current research studying the combination of genetic and environmental factors involved in substance use disorders is poorly understood. More research is needed, particularly to identify which adolescents are most at risk and to develop effective interventions addressing contributing factors such as trauma and psychiatric comorbidity.
- Details
- Hits: 1460
04 July 2020
Background and Aims: Cannabis use disorder (CUD) is frequent in adolescence and often goes into remission towards adulthood. This study aimed to estimate trajectories of CUD severity (CUDS) in Swiss men from 20 to 25 years old and to identify prospective predictors of these trajectories.
Participants: 5987 Swiss men assessed longitudinally at the mean ages of 20, 21.5 and 25 years old.
Measurements: Latent CUDS in the last 12 months was measured at each wave with the Cannabis Use Disorders Identification Test Revised (CUDIT‐R). Predictors of CUDS trajectories, measured at age 20, were from six domains: factors related to cannabis use, family, peers, other substance use, mental health and personality.
Conclusions: Factors associated with persistent cannabis use disorder in young Swiss men include cannabis use, cannabis use disorder severity, mental health problem severity, relationship with parents (before the age of 18), peers with drug problems, and the personality dimensions neuroticism‐anxiety and sociability at or before age 20. Effect sizes may be small and predictors are mainly associated with persistence via higher severity at age 20.